Zai Lab (ZLAB) Shares Outstanding (2016 - 2026)

Zai Lab (ZLAB) posted Shares Outstanding (Entity) of $1.1 billion for Q1 2026, little changed sequentially from $1.1 billion in Q4 2025, and up 2.73% YoY from $1.1 billion in Q1 2025.

Zai Lab (ZLAB) Shares Outstanding (2016 - 2026) Analysis & Trends

Zai Lab has reported Shares Outstanding (Entity) for 11 years, with the latest figure at $1.1 billion in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 2.73% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 2.73% YoY) and the FY2025 annual result came in at $1.1 billion, up 2.88% from the prior year.
  • Shares Outstanding (Entity) steadied at $1.1 billion in Q1 2026 per ZLAB's latest filing, from $1.1 billion in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $1.1 billion in Q1 2026 and troughed at $957.0 million in Q1 2022.
  • A 5-year average of $1.0 billion and a median of $978.2 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) gained 0.74% in 2022, then climbed 12.54% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $962.5 million in 2022, then rose by 1.53% to $977.2 million in 2023, then climbed by 10.79% to $1.1 billion in 2024, then gained by 2.88% to $1.1 billion in 2025, then climbed by 0.45% to $1.1 billion in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $1.1 billion, $1.1 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.19 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.45 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 445.06 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.61 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Zai Lab 2.91 Bn 2.20 Bn 58.15 Mn 1.12 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.12 Bn
Mar 31, 2026 1.11 Bn
Dec 31, 2025 1.10 Bn
Sep 30, 2025 1.10 Bn
Jun 30, 2025 1.09 Bn
Mar 31, 2025 1.08 Bn
Dec 31, 2024 989.48 Mn
Sep 30, 2024 981.69 Mn
Jun 30, 2024 975.94 Mn
Mar 31, 2024 973.15 Mn
Dec 31, 2023 966.39 Mn
Sep 30, 2023 968.77 Mn
Jun 30, 2023 964.82 Mn
Mar 31, 2023 961.44 Mn
Dec 31, 2022 958.07 Mn
Sep 30, 2022 959.09 Mn
Jun 30, 2022 957.68 Mn
Mar 31, 2022 955.50 Mn
Dec 31, 2021 929.92 Mn
Sep 30, 2021 950.35 Mn